BridgeMD
New treatment option for Bladder Cancer
Official title Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
ClinicalTrials.gov ID: NCT05779631
What this study is testing
- What it's testing
- A two-arm multicenter randomised controlled trial, comparing progression free survival, time to definitive treatment and cost-effectiveness of the standard of care (TURBT) and mpMRI followed by same-day cystoscopic bladder biopsy for diagnosis of patients with suspicion of muscle-invasive bladder cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients (18+ years of age)
- Clinically suspected MIBC
- No lymph node or distant metastases
- Written informed consent
You likely can't join if
- Unable or unwilling to undergo mpMRI
- Unfit for TURBT
- Unfit for definitive treatment with curative intent
- A history of cancer, including bladder cancer, except: non-melanoma skin cancer, prostate cancer on active surveillance or a solid malignant tumor ≥5...
The study team makes the final eligibility decision.
Where it's taking place
- 's-Hertogenbosch, Netherlands
- Almelo, Netherlands
- Amersfoort, Netherlands
- Amsterdam, Netherlands
- Arnhem, Netherlands
- Boxmeer, Netherlands
- Ede, Netherlands
- Emmen, Netherlands
- Enschede, Netherlands
- Nieuwegein, Netherlands
- Nijmegen, Netherlands
- Rotterdam, Netherlands
- Uden, Netherlands
- Utrecht, Netherlands
- Venlo, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include 's-Hertogenbosch, Netherlands; Almelo, Netherlands; Amersfoort, Netherlands; Amsterdam, Netherlands; Arnhem, Netherlands; Boxmeer, Netherlands and 9 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.